Discussing uncertainty and risk in primary care: Recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening

Journal of General Internal Medicine

Volumn 28, Issue 11, 2013, Pages 1410-1419

  Wilkes, Michael ^a   Srinivasan, Malathi ^a   Cole, Galen ^b   Tardif, Richard ^c   Richardson, Lisa C ^b   Plescia, Marcus ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

communication; funding priorities; men's health; prostate cancer screening; risk; shared decision making

Indexed keywords

ACCREDITATION; ARTICLE; CANCER RISK; CANCER SCREENING; DECISION MAKING; DECISION SUPPORT SYSTEM; DOCTOR PATIENT RELATION; ELECTRONIC MEDICAL RECORD; HEALTH CARE SYSTEM; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL INFORMATION; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROSTATE CANCER; REIMBURSEMENT; UNCERTAINTY;

EARLY DETECTION OF CANCER; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROSTATIC NEOPLASMS; RISK FACTORS; UNCERTAINTY;

EID: 84885950262     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2419-z     Document Type: Article

References (55)

1. Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the US Preventive Services Task Force. Ann Intern Med. 2008;149:192-9.
2. Chou R, Croswell JM, Dana T, Bougatsos C, et al. Screening for prostate cancer: a review of the evidence for the US Preventive services task force. Ann Intern Med. 2011;155(11):762-71.
3. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185-91.
4. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010. Available at: www.cdc.gov/uscs.
5. Legare F, Ratte S, Stacey D, Kryworuchko J, Gravel K, Graham ID, Turcotte S. Interventions for Improving the Adoption of Shared Decision Making by Healthcare Professionals (Review). John Wiley & Sons, Ltd.; 2010.
6. McKinstry B. Do patients wish to be involved in decision making in the consultation? A cross-sectional survey with video vignettes. BMJ. 2000;321:867-71.
7. Say RE, Thomson R. The importance of patient preferences in treatment decisions - challenges for doctors. BMJ. 2003;327:542-5.
8. Braddock CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practice: time to get back to basics. JAMA. 1999;282:2313-20.
9. Godolphin W. Understanding decision-making in healthcare and law. Healthc Qual. 2007;12:186-90.
10. Pignone M. Weighing the benefits and downsides of prostate-specific antigen screening. Arch Intern Med. 2009;169(17):1554-5.
11. Barratt AL, Stockler MR. Screening for prostate cancer: explaining how new trial results and their implications to patients. MJA. 2009;191(4):226-9.
12. Smith RA, Cokkinides V, Levin B, et al. American Cancer Society guidelines for the early of detection of cancer. The American Cancer Society. CA Cancer J Clin. 2002;52:8-22.
13. American Medical Association. Cancer screening guidelines [perform a search for specific types of cancer]. Retrieved September 20, 2000, from the World Wide Web: http://www.ama-assn.org.
14. National Health Service. 2011. http://www.cancerscreening.nhs.uk/ prostate/prostate-patient-info-sheet.pdf
15. American Cancer Society. Revised Prostate Cancer Screening Guidelines: What Has - and Hasn't - Changed. 2010. Retrieved Jan 2012. http://www.cancer. org/Cancer/news/News/revised-prostate-cancer-screening-guidelines
16. USPSTF. May 2012. http://www.uspreventiveservicestaskforce.org/ prostatecancerscreening.htm
17. Ransohoff DF, Collins MM, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 2002;113:663-7.
18. Aronowitz RA. Do not delay: breast cancer and time, 1900-1970. Milbank Q. 2001;9(3):355-86.
19. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-8.
20. Barry MJ, Wescott PH, Reifler EJ, Chang Y, Moulton BW. Reactions of potential jurors to a hypothetical malpractice suit alleging failure to perform a prostate-specific antigen test. J Law Med Ethics. 2008;36(2):396-402, 214.
21. Merenstein D. A piece of my mind. Winners and losers. JAMA. 2004;291(1):15-6.
22. Kahneman D, Tversky A. Choices, values, and frames. Am Psychol. 1984;39:341-50.
23. Keller PA, Lehmann DR. Designing effective health communications: a meta-analysis. J Public Policy Mark. 2008;27(2):117-30.
24. Andreasen AR. Social Marketing in the 21st Century. Thousand Oaks: Sage Publications; 2006.
25. Dobrow MJ, Goel V, Lemieux-Charles L, Black NA. The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations. Soc Sci Med. 2006;63:1811-24.
26. Kerfoot BP, Holmberg EF, Lawler EV, Krupat E, Conlin PR. Practitioner-level determininants of inappropriate prostate-specific antigen screening. Arch Intern Med. 2007;167(13):1367-72.
27. Elwyn G, Frosch D, Volandes AE, Edwards A, Montori VM. Investing in deliberation: a definition and classification of decision support interventions for people facing difficult health decisions. Med Decis Making. 2010;30(6):701-11.
28. Farrell MH, Murphy MA, Schneider CE. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing. Eff Clin Pract. 2002;5(3):120-9.
29. Wolf SH. Screening for prostate cancer. In: United States Preventative Services Task Force, ed. The Guide to Clinical Preventative Services. 2nd ed. Baltimore: Williams & Wilkins; 1996:119-34.
30. Brody H. Transparency: informed consent in primary care. Hast Cent Rep. 1989;19:5-9.
31. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;(10):CD001431.
32. Hoffman JR, Wilkes MS, Day FC, Bell DS, Higa JK. The roulette wheel: an aid to informed decision making. PLoS Med. 2006;3(6):e137. doi: 10.1371/journal.pmed.
33. Epstein RM, Street RL, Jr. Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. National Cancer Institute, NIH Publication No. 07-6225. Bethesda, MD, 2007.
34. Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.
35. Scott JC, Robertson BJ. Kaiser Colorado's Cooperative Health Care Clinic: a group health approach to patient care. Manag Care Q. 4(3):41-5.
36. Chaloupka F. Macro-social influences: the effects of prices and tobacco control policies on the demand for tobacco products. Nicotine Tob Res. 1999;1(Suppl 1):S105-9.
37. Chaloupka F, Pacula R. An Examination of Gender and Race Differences in Youth Smoking Responsiveness to Price and Tobacco Control Policies, National Bureau of Economic Research, Working Paper 6541, April 1998.
38. Hu T-W, Sung HY, Keeler TE. Reducing cigarette consumption in California: tobacco taxes vs an anti-smoking media campaign. Am J Public Health. 1995;85:1218-22.
39. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590-9.
40. Cohen DA, Wu S, Farley TA. Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr. 2004;37:1404-14.
41. Wagenaar A, Tobler AL, Komro KA. Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. Am J Public Health. 2010;100:2270-8.
42. Guide to Community Preventive Services. Cancer prevention & control, provider-oriented screening interventions: assessment & feedback (abbreviated). www.thecommunityguide.org/cancer/screening/provider-oriented/ assessment-a.html. Accessed 12/12/2011.
43. Volk RJ, Hawley SK, Holden EW, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007;33:428-34.
44. Elwyn G, Edwards A, Gwyn R, Grol R. Towards a feasible model for shared decision making: focus group study with general practice registrars. BMJ. 1999;319:753-6.
45. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ. 2002;324:827-30.
46. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ. 2003;327:741-4.
47. Paling J. Strategies to help patients understand risks. BMJ. 2003;327:745-8.
48. Barratt A, Trevena L, Davey HM, McCaffery K. Use of decision aids to support informed choices about screening. BMJ. 2004;329:507-10.
49. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;3:CD001431.
50. Legare F, Ratte S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals' perceptions. Patient Educ Couns. 2008;73(3):526-35.
51. Kawamoto K, Houlihan C, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.
52. ACGME General Competencies: Competency Definitions and Recommended Practice Performance Tools. Accreditation Council for Graduate Medical Education. Chicago, IL. posted: October 18, 2007. http://www.acgme.org/ acWebsite/RRC-430/430-CompetencyDefinitions-RO-ED-10182007.pdf (Accessed: January 28, 2012)
53. Cantillon P. Does continuing medical education in general practice make a difference? BMJ. 1999;318:1276.
54. Davis DA, Thomson MA, Oxman AD, et al. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274(9):700-5.
55. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care. 2005;21(3):380-5.